Second Alzheimer's drug in the pipeline promises to slo...
New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening
Source: accesswdun.com
Stay updated with breaking news from Mark Mintun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening
Drugmaker has completed its FDA submission for approval of donanemab, with regulatory action expected by the end of this year
Donanemab significantly slowed cognitive and functional decline for amyloid-positive early symptomatic Alzheimer's disease patients, lowering their risk of...
A new drug has been hailed as a "turning point in the fight against Alzheimer's" after it was found to slow the progression of the…